Core Viewpoint - Shanghai Industrial Holdings (00363) reported a revenue of HKD 28.918 billion and a net profit of HKD 2.808 billion for the fiscal year 2024, with earnings per share at HKD 2.582 and a final dividend of HKD 0.52 per share [1] Group 1: Infrastructure and Environmental Business - The infrastructure and environmental business generated a profit of HKD 2.629 billion, representing a 13.3% increase from the previous year, primarily due to the sale of equity during the public infrastructure investment fund (REIT) issuance for the Hangzhou Bay Bridge, contributing approximately 85.1% to the group's net profit [1] - The company continues to align with national strategies, focusing on water treatment and resource utilization to expand market share and enhance efficiency, solidifying its leading position in China's water and environmental industry [1] Group 2: Healthcare Business - The healthcare segment reported a profit of HKD 54.23 million, accounting for about 1.8% of the group's net profit. Shanghai Pharmaceuticals (Group) Co., Ltd. achieved a revenue of RMB 274.693 billion, a 5.5% increase year-on-year, while net profit decreased by 11.98% to RMB 870 million, mainly due to a reduction in net gains from the disposal of non-listed assets [1] - Shanghai Pharmaceuticals holds a 19.348% stake in Shanghai Pharmaceuticals Holding Co., Ltd., making it the largest single A-share shareholder [1] Group 3: Real Estate Business - The real estate segment incurred a loss of HKD 236 million, a shift from profit to loss compared to the previous year, contributing approximately -7.7% to the group's net profit, primarily due to a significant decrease in revenue from property handovers [2] - The "Shanghai Industrial Haishang Bay" project, in which the company holds a 49% stake, had previously provided substantial profit contributions through property revenue recognition [2] Group 4: Consumer Goods Business - The consumer goods segment contributed a profit of HKD 643 million, a 71.8% increase from the previous year, accounting for about 20.8% of the group's net profit [2] - The macroeconomic environment remains complex, with the consumer goods market showing moderate recovery, driven by Nanyang Brothers Tobacco Co., Ltd.'s proactive market strategies and sales growth [2] - Yongfa Printing Co., Ltd. achieved steady performance improvements through enhanced asset operation efficiency and recovery in the cigarette packaging business [2]
上海实业控股(00363)2024年实现净利润28.08亿港元 末期息每股52港仙